Statement
26 Sep 2023
IFPMA and industry leaders applaud 10 years of collective action on ethics and business integrity in APEC region
Washington, D.C. and Geneva, 26 September 2023: This week, IFPMA joins hundreds of stakeholders from across economies in the Asia-Pacific at the APEC Business Ethics for SMEs Forum to recognize and applaud progress made by the initiative in the past decade to advance business ethics in the medical device and biopharmaceutical sectors in the region....
Read more
Position paper
15 May 2023
IFPMA Note for Guidance on sponsorship of events and meetings (2023 update)
Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.
Read more
Position paper
28 Sep 2022
Joint Note for Guidance on social media and digital channels
In a new Note for Guidance, IFPMA and EFPIA provide non-binding advice for their members when considering their activities on social media and digital channels. The document seeks to support and guide pharmaceutical companies and associations and anyone acting on their behalf in always basing their cooperation with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs), Patient...
Read more